Treatment and implications of multidrug-resistant tuberculosis for the 21st century

Chemotherapy

Volumn 45, Issue , 1999, Pages 34-40

  Iseman, Michael D ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Developing nations; Directly observed therapy; DOT; MDR TB; Multidrug resistant tuberculosis; Resistance

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SPARFLOXACIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

CLINICAL PRACTICE; CONFERENCE PAPER; HEALTH PROGRAM; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MEDICAL EDUCATION; MULTIDRUG RESISTANCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; TREATMENT FAILURE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; EDUCATION, MEDICAL, CONTINUING; FORECASTING; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; WORLD HEALTH;

EID: 0032858610     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000048480     Document Type: Article

References (6)

1. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA: Tuberculosis in New York City - Turning the tide. N Engl J Med 1995;333:229-233.
2. Iseman M: Treatment of multi-drug resistant tuberculosis. N Engl J Med 1993;784-791.
3. Mahmoudi A, Iseman MD: Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. JAMA 1995;270:65-68.
4. Goble M, Iseman MD, Madsen LA, Waite D, Ackerson L, Horsburgh CR Jr: Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993;328:527-532
5. Iseman MD, Madsen L, Goble M, Pomerantz M: Surgical intervention in the treatment of pulmonary disease caused by drug-resistant Mycobacterium tuberculosis. Am Rev Respir Dis 1990;141:623-625.
6. Crofton J, Chaulet P, Mahet D: Guidelines for the Management of Drug-Resistant Tuberculosis. 1997, Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.